In ongoing investigation with the Southern Alberta Marijuana Investigative Team two individuals are being charged with production of marijuana, and theft of utilities. The two persons charged include one member of the civilian staff of the Calgary Police Service.

In Depth Study Reveals Drug Increases Risk Of Death

Rockland, Maryland- The results are in and it doesn’t look good for the Anti Bleeding Drug Trasylol, which has now been linked with increased numbers of deaths for patients who had the drug during surgery.

In a study by researchers at Vanderbilt University School of Medicine, the drug Trasylol was found to show that patients that received the medication during heart surgery were much more likely to suffer complications and even death than others who were not given Trasylol.

The maker of the drug, Bayer AG has not yet decided what to do about the drug, and wants to wait for the results and full details of the Canadian study, but it does not look good for the drug’s future. There are many lawsuits currently pending against Bayer that claim that Trasylol causes excessive death and that the Bayer company hid this from patients.

In findings released on Wednesday by the New England Journal of Medicine, the head to head study of Trasylol and two additional drugs were examined. Trasylol was first given the green light for patients in 1993 but questions eventually surfaced in 2006 when it was first linked to increased risks of stroke, heart attack and kidney failure, and in some cases even death.